$CUTOFFSJoin us

$CUTOFFSJoin us

Nurix Therapeutics, Inc.

Current report (Form 8-K) · Jun 8, 2026 · Material agreement · Investor press release · Financial statements

Company

Nurix Therapeutics, Inc.

Documents

27

Primary topic

Material agreement

Filed

Jun 8, 2026


8-K	nrix-20260606.htm	1 B
Complete text	0001549595-26-000030.txt	3.4 MB
EX-99.1	ex991_nurixpressrelease202.htm	2 B
EX-99.2	ex992_nurixpresentation2.htm	3 B
EX-101.SCH	nrix-20260606.xsd	4 B
EX-101.LAB	nrix-20260606_lab.xml	5 B
EX-101.PRE	nrix-20260606_pre.xml	6 B
GRAPHIC	ex992_nurixpresentation2001.jpg	7 B
GRAPHIC	ex992_nurixpresentation2002.jpg	8 B
GRAPHIC	ex992_nurixpresentation2003.jpg	9 B
GRAPHIC	ex992_nurixpresentation2004.jpg	10 B
GRAPHIC	ex992_nurixpresentation2005.jpg	11 B
GRAPHIC	ex992_nurixpresentation2006.jpg	12 B
GRAPHIC	ex992_nurixpresentation2007.jpg	13 B
GRAPHIC	ex992_nurixpresentation2008.jpg	14 B
GRAPHIC	ex992_nurixpresentation2009.jpg	15 B
GRAPHIC	ex992_nurixpresentation2010.jpg	16 B
GRAPHIC	ex992_nurixpresentation2011.jpg	17 B
GRAPHIC	ex992_nurixpresentation2012.jpg	18 B
GRAPHIC	ex992_nurixpresentation2013.jpg	19 B
GRAPHIC	ex992_nurixpresentation2014.jpg	20 B
GRAPHIC	ex992_nurixpresentation2015.jpg	21 B
GRAPHIC	ex992_nurixpresentation2016.jpg	22 B
GRAPHIC	ex992_nurixpresentation2017.jpg	23 B
GRAPHIC	ex992_nurixpresentation2018.jpg	24 B
GRAPHIC	ex992_nurixpresentation2019.jpg	25 B
XML	nrix-20260606_htm.xml	36 B

View original filing

Related

All SEC filings Signals